Duffy E, Ward J, Hale L, Brown K, Kwilasz A, Mehrhoff E
Front Psychiatry. 2025; 15:1505898.
PMID: 39758444
PMC: 11695335.
DOI: 10.3389/fpsyt.2024.1505898.
Kudrina I, Page M, Choiniere M, Shir Y, Eisenberg M, Ben-Sasson M
BMJ Open. 2024; 14(10):e083791.
PMID: 39414287
PMC: 11481125.
DOI: 10.1136/bmjopen-2023-083791.
Sharpe A, Liter L, Donohue D, Carter K, Vangeneugden P, Weaver S
bioRxiv. 2024; .
PMID: 39282417
PMC: 11398421.
DOI: 10.1101/2024.09.03.611052.
Panayi M, Schoenbaum G
Behav Neurosci. 2024; 138(4):291-300.
PMID: 39250296
PMC: 11874615.
DOI: 10.1037/bne0000606.
Victor G, Kheibari A, Strickland J
Community Ment Health J. 2024; 61(3):411-419.
PMID: 39235576
PMC: 11868299.
DOI: 10.1007/s10597-024-01345-9.
Pannexin-1 channel inhibition alleviates opioid withdrawal in rodents by modulating locus coeruleus to spinal cord circuitry.
Kwok C, Harding E, Burma N, Markovic T, Massaly N, van den Hoogen N
Nat Commun. 2024; 15(1):6264.
PMID: 39048565
PMC: 11269731.
DOI: 10.1038/s41467-024-50657-7.
Comparing intravenous lidocaine and pethidine for pain management in emergency department patients with femoral bone fracture: a randomized controlled trial.
Eftekhar S, Hazrati E, Mosaed R, Dini S, Galougahi M, Namazi M
BMC Anesthesiol. 2024; 24(1):250.
PMID: 39044154
PMC: 11264420.
DOI: 10.1186/s12871-024-02640-4.
Negative allosteric modulation of CB cannabinoid receptor signaling suppresses opioid-mediated tolerance and withdrawal without blocking opioid antinociception.
Iyer V, Saberi S, Pacheco R, Sizemore E, Stockman S, Kulkarni A
Neuropharmacology. 2024; 257:110052.
PMID: 38936657
PMC: 11261750.
DOI: 10.1016/j.neuropharm.2024.110052.
At a Crossroads: Opioid Use Disorder, the X-Waiver, and the Road Ahead.
Dhillon J, Feulner L, Beitollahi A, Kossen K, Galarneau D
Ochsner J. 2024; 24(2):108-117.
PMID: 38912181
PMC: 11192224.
DOI: 10.31486/toj.23.0074.
The influence of transformations in supply on methamphetamine initiation among people injecting opioids in the United States.
Mars S, Ondocsin J, Holm N, Ciccarone D
Harm Reduct J. 2024; 21(1):57.
PMID: 38443903
PMC: 10913463.
DOI: 10.1186/s12954-024-00976-1.
Safety and efficacy of low-dose esketamine in laparoscopic cholecystectomy: a prospective, double-blind randomized controlled trial.
Zhao L, Li Z, Jin B, Hou N, Yang H
BMC Anesthesiol. 2024; 24(1):47.
PMID: 38302944
PMC: 10832235.
DOI: 10.1186/s12871-024-02429-5.
Pathways to opioid use and implications for prevention: voices of young adults in recovery.
Ballard P, Arnold T, Vidrascu E, Hernandez G, Ozer E, Wolfson M
Subst Abuse Treat Prev Policy. 2024; 19(1):8.
PMID: 38238852
PMC: 10795392.
DOI: 10.1186/s13011-023-00584-5.
Causation and Common Liability in the Progression of the U.S. Opioid Crisis.
Dash G, Conlin W, Winograd R
J Stud Alcohol Drugs. 2023; 85(1):12-18.
PMID: 38095266
PMC: 10846605.
DOI: 10.15288/jsad.23-00289.
Noninvasive Vagal Nerve Stimulation for Opioid Use Disorder.
Douglas Bremner J, Gazi A, Lambert T, Nawar A, Harrison A, Welsh J
Ann Depress Anxiety. 2023; 10(1).
PMID: 38074313
PMC: 10699253.
Prevalence and correlates of DSM-5 opioid withdrawal syndrome in U.S. adults with non-medical use of prescription opioids: results from a national sample.
Mannes Z, Livne O, Knox J, Hasin D, Kranzler H
Am J Drug Alcohol Abuse. 2023; 49(6):799-808.
PMID: 37948571
PMC: 10867630.
DOI: 10.1080/00952990.2023.2248646.
Psychoactive drugs and male fertility: impacts and mechanisms.
Hamed M, Ekundina V, Akhigbe R
Reprod Biol Endocrinol. 2023; 21(1):69.
PMID: 37507788
PMC: 10375764.
DOI: 10.1186/s12958-023-01098-2.
Intentional use of both opioids and cocaine in the United States.
Liu X, Singer M
Prev Med Rep. 2023; 33:102227.
PMID: 37223567
PMC: 10201855.
DOI: 10.1016/j.pmedr.2023.102227.
Transcutaneous Cervical Vagus Nerve Stimulation Reduces Respiratory Variability in the Context of Opioid Withdrawal.
Gazi A, Harrison A, Lambert T, Obideen M, Welsh J, Vaccarino V
IEEE EMBS Int Conf Biomed Health Inform. 2023; 2022.
PMID: 37143708
PMC: 10155675.
DOI: 10.1109/bhi56158.2022.9926787.
Predicting Patient Satisfaction With Medications for Treating Opioid Use Disorder: Case Study Applying Natural Language Processing to Reviews of Methadone and Buprenorphine/Naloxone on Health-Related Social Media.
Omranian S, Zolnoori M, Huang M, Campos-Castillo C, McRoy S
JMIR Infodemiology. 2023; 3:e37207.
PMID: 37113381
PMC: 9987197.
DOI: 10.2196/37207.
Negative allosteric modulation of CB cannabinoid receptor signaling suppresses opioid-mediated reward.
Iyer V, Rangel-Barajas C, Woodward T, Kulkarni A, Cantwell L, Crystal J
Pharmacol Res. 2022; 185:106474.
PMID: 36179954
PMC: 9948526.
DOI: 10.1016/j.phrs.2022.106474.